-
Affordable GRO-seq in Bread Wheat: Study Insights
2026-08-26
This STAR Protocols study presents a cost-conscious GRO-seq workflow for profiling nascent transcription in allohexaploid bread wheat. Its central innovation is rRNA depletion after nuclear RNA isolation and before nascent RNA immunoprecipitation, which increased the proportion of valid data by 20-fold and improved enhancer-transcription analysis in a complex plant genome.
-
Epoxomicin: A Causal Probe of RIPK3 Degradation
2026-08-25
Epoxomicin is a selective, irreversible proteasome inhibitor that can turn proteasome-dependent RIPK3 loss into a testable mechanistic hypothesis. This article translates viral inflammation findings into practical assay design, controls, interpretation rules, and reproducible handling guidance.
-
PERK Loss Promotes Ferroptosis in Colorectal Cancer
2026-08-25
The reference study identifies PERK as a negative regulator of ferroptosis in colorectal cancer by linking PERK–ATF4 signaling to SLC7A11 expression. Its findings suggest that suppressing this stress-adaptation pathway can increase lipid peroxidation and restrict tumor growth, providing a mechanistic framework for apoptosis-resistant cancer models.
-
N-octanoyl-L-Homoserine Lactone (C8-HSL)
2026-08-24
N-octanoyl-L-Homoserine lactone, also called C8-HSL, is a diffusible bacterial quorum-sensing molecule that can regulate LuxR-type transcriptional responses. Recent evidence also links C8-HSL exposure to PI3K/AKT/ERK-dependent proliferation, migration, and invasion of H460 lung cancer cells, while product specifications support controlled microbiology and infection biology research.
-
Blebbistatin for Causal Cell Mechanics Imaging
2026-08-24
Blebbistatin enables reversible interrogation of non-muscle myosin II in migration, adhesion, and morphology assays. This guide shows how to combine the perturbation with structure–function imaging principles from panoramic cardiac mapping for stronger causal interpretation.
-
NAT1–ENO1–Lactate Signaling in Colorectal Cancer
2026-08-23
This MedComm study identifies a NAT1–ENO1–lactate pathway that links tumor glycolysis to TRAF6-dependent PD-L1 stabilization and immune escape in colorectal cancer. Its combination of multi-omics, mechanistic protein analysis, patient-associated data, and mouse immunotherapy models suggests that disrupting lactate signaling may improve checkpoint blockade, while also defining practical endpoints for metabolic–immune studies.
-
N-octanoyl-L-Homoserine lactone in Cell Assays
2026-08-22
Learn how N-octanoyl-L-Homoserine lactone (SKU C3579) can improve the design and interpretation of quorum-sensing, infection biology, and host-cell viability experiments. This scenario-based guide covers formulation, controls, assay compatibility, dose optimization, and vendor-selection considerations.
-
Sodium Nitroprusside in Sex-Specific Vascular Research
2026-08-22
Sodium Nitroprusside provides a practical nitric oxide donor tool for separating vascular smooth muscle, platelet, and autonomic components of hypertension. Used alongside telemetry and isolated-vessel assays, it can turn sex-dependent blood-pressure phenotypes into testable mechanisms rather than descriptive observations.
-
IGF2BP1–TUBB4B Signaling in Liver Fibrosis
2026-08-21
The reference study identifies an m6A-dependent IGF2BP1–TUBB4B–FAK pathway that promotes hepatic stellate cell activation, proliferation, and migration. Its combination of transcriptomic re-analysis, RNA-binding and m6A profiling, genetic perturbation, and pharmacological validation provides a useful framework for dissecting methylation-linked mechanisms in liver fibrosis.
-
Acifran: From Receptor Structure to Assay Design
2026-08-20
Acifran is a structurally resolved HCAR2/HCAR3 agonist for lipid metabolism research. This guide translates cryo-EM findings into practical choices for receptor, cAMP, selectivity, and compound-handling assays.
-
DiscoveryProbe Natural Product Library Plus for HTS
2026-08-20
Use the DiscoveryProbe Natural Product Library Plus to connect target-based enzyme assays with cell-based phenotypic and high-content screening. Its pre-dissolved, quality-checked format supports practical hit discovery, while Cryptosporidium AdhE research illustrates how biochemical inhibition can be linked to antiparasitic efficacy.
-
Bone-Penetrating Copper Nanoassembly for Cancer Therapy
2026-08-19
The reference study presents BCB, a baicalein–copper coordinated nanoassembly incorporating a boron-dipyrromethene photosensitizer to combine chemodynamic therapy, photodynamic therapy, and cuproptosis. Its tumor-microenvironment-responsive behavior, bone penetration, and reported 75% cure rate in an irradiated murine melanoma model indicate a strategy for addressing both treatment resistance and poor access to intramedullary tumors.
-
Exendin-4 Workflows for Beta Cell Research
2026-08-19
Exendin-4, also known as Exenatide, connects cAMP signaling to practical beta cell, metabolic, neuronal, and recombinant-expression workflows. This guide translates its documented activity into dose planning, assay controls, yeast-expression validation, and troubleshooting strategies for reproducible type 2 diabetes research.
-
Caspase-8 Fluorometric Assay Kit for Cell Death
2026-08-18
Translate treatment-induced caspase-8 activation into a quantitative fluorescence readout for apoptosis, combination-therapy, and neurodegeneration workflows. This guide connects IETD-AFC assay design with the hyperthermia–cisplatin mechanism reported in recent cancer research.
-
HyperPFU™ high-fidelity DNA polymerase Guide
2026-08-18
HyperPFU™ high-fidelity DNA polymerase is intended for accurate amplification of long, GC-rich, inhibitor-affected, or otherwise difficult DNA templates. It is appropriate for blunt-ended cloning and sequencing workflows, but not for protocols that require 3′-A overhangs or sticky-end products.